OAM
Optimal Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $2.18M | Buy |
22,773
+46
| +0.2% | +$4.41K | 0.27% | 137 |
|
|
2021
Q2 | $2.21M | Hold |
22,727
| – | – | 0.26% | 143 |
|
|
2021
Q1 | $2.21M | Buy |
22,727
+6,400
| +39% | +$622K | 0.29% | 133 |
|
|
2020
Q4 | $1.57M | Hold |
16,327
| – | – | 0.22% | 160 |
|
|
2020
Q3 | $1.57M | Buy |
16,327
+4,951
| +44% | +$476K | 0.23% | 144 |
|
|
2020
Q2 | $1.39M | Sell |
11,376
-1,273
| -10% | -$155K | 0.23% | 150 |
|
|
2020
Q1 | $1.1K | Buy |
+12,649
| New | +$1.1K | 0.1% | 280 |
|